Nutex Health Inc. Common Stock

Day range

$210.92 – $225.00

Open

$213.69

Prev close

$209.59

Volume

150.96K

Market cap

$1.44B

Shares out

6.85M

P/E

7.98

P/S

1.70

P/B

3.64

P/FCF

5.23

ROE

45.6%

ROA

18.6%

Debt/Equity

0.80

Div yield

1.31%

As of Oct 23, 2026

• Cybersecurity incidentSep 11, 2026

  On September 10, 2026, we issued a press release containing an update on a previously announced cyber security event.

• Class action filingAug 31, 2026

  Following the filing of the Prior 8-K, a purported class action complaint captioned Haley v. Nutex Health, Inc., Case No. 4:26-cv-07197, was filed on August 27, 2026, against the Company in the United States District Court for the Southern District of Texas, Houston Division. The complaint was filed on behalf of a putative class of all individuals whose personally identifiable information and/or protected health information was allegedly accessed and/or acquired by an unauthorized party in connection with the incident.

• Cybersecurity incidentAug 24, 2026

  Nutex Health Inc. (the "Company") recently learned of unauthorized activity involving data stored on its computer network. Based on preliminary findings from the Company's ongoing investigation, the Company believes that certain information maintained on the Company's servers was accessed and exfiltrated by an unauthorized third party, including some information that may be private and/or confidential.

• Regulatory decisionAug 13, 2026

  On August 11, 2026, the Fifth Circuit Court of Appeals issued an en banc decision in Texas Medical Association v. HHS, No. 23-40605, vacating key portions of the July 2021 interim final rule (July 2021 Rule) promulgated by the Departments of Health and Human Services, Labor, and Treasury (Departments). The vacated provisions had allowed the inclusion of 'ghost rates' and excluded bonus and incentive payments from the calculation of the Qualifying Payment Amount (QPA) under the No Surprises Act (NSA).

• Regulatory decisionJul 21, 2026

  On June 4, 2026, CMS and federal agencies reduced the non-refundable administrative fee for the Federal IDR process from $115 to $15 per party per dispute. This reduction took effect on June 11, 2026, to lower financial barriers for healthcare providers and payers. As a result of the Amendment and the recently adopted new CMS Rules, the Company expects a reduction in our overall arbitration related costs.

Days to cover

8.2

Short interest

1.25M

Avg volume

152.6K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• 2 Stocks to Buy Hand Over Fist in October
  positiveThe Motley Fool· Oct 8, 2026
• 5 Stocks With Recent Price Strength After a Mixed September
  positiveZacks Investment Research· Oct 5, 2026
• Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns
  positiveZacks Investment Research· Oct 1, 2026
• 4 Stocks With Solid Net Profit Margins to Boost Portfolio Returns
  positiveZacks Investment Research· Aug 27, 2026
• $ALDX ALERT: Aldeyra Therapeutics, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
  negativeGlobeNewswire Inc.· Mar 17, 2026